BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,448,000 | -52.6% | 12,216 | -44.4% | 0.27% | -47.6% |
| Q3 2021 | $3,054,000 | +30.8% | 21,989 | -8.6% | 0.52% | +42.7% |
| Q2 2021 | $2,335,000 | +368.9% | 24,048 | +230.1% | 0.36% | +381.3% |
| Q1 2021 | $498,000 | -62.4% | 7,286 | -52.8% | 0.08% | -65.4% |
| Q4 2020 | $1,324,000 | +29.3% | 15,447 | -1.9% | 0.22% | -10.7% |
| Q3 2020 | $1,024,000 | -52.3% | 15,752 | -46.4% | 0.24% | -48.8% |
| Q2 2020 | $2,148,000 | -17.4% | 29,385 | -50.5% | 0.48% | -25.3% |
| Q2 2019 | $2,600,000 | -18.3% | 59,383 | -4.0% | 0.64% | -18.6% |
| Q1 2019 | $3,183,000 | – | 61,836 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |